ESCORA Trademark
Trademark Overview
On Wednesday, January 16, 2002, a trademark application was filed for ESCORA with the United States Patent and Trademark Office. The USPTO has given the ESCORA trademark a serial number of 78103087. The federal status of this trademark filing is ABANDONED - EXPRESS as of Friday, May 9, 2003. This trademark is owned by Pfizer Inc.. The ESCORA trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations
General Information
| Serial Number | 78103087 |
| Word Mark | ESCORA |
| Filing Date | Wednesday, January 16, 2002 |
| Status | 601 - ABANDONED - EXPRESS |
| Status Date | Friday, May 9, 2003 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 1000 - Typeset: Word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, August 13, 2002 |
Trademark Statements
| Goods and Services | Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, cholesterol preparations, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 7, 2002 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Pfizer Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
| Party Name | Pfizer Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10017 |
Trademark Events
| Event Date | Event Description |
| Friday, May 9, 2003 | ABANDONMENT - EXPRESS MAILED |
| Friday, May 9, 2003 | PAPER RECEIVED |
| Tuesday, November 5, 2002 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 13, 2002 | PUBLISHED FOR OPPOSITION |
| Wednesday, July 24, 2002 | NOTICE OF PUBLICATION |
| Saturday, May 18, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, May 9, 2002 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Monday, May 6, 2002 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, May 3, 2002 | ASSIGNED TO EXAMINER |
